search
Company Information
USD
14.74
- (1.7%)
NASDAQ:ANIK, ANIKA THERAPEUTICS, INC.
Industry: Medical Instruments & Supplies
End of Day: 8 May 2025 GMT-4
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.

Address

32 Wiggins Avenue

Classification

Sector

Healthcare

Industry Group

Medical Devices & Instruments

Industry

Medical Instruments & Supplies

Key Executives

Mr. John B. Henneman, III
Chairman of the Board/Director
Mr. Jeffery Scott Thompson
Director
Mr. Gary P. Fischetti
Director
Ms. Anne Nunes
COO/Senior VP
Dr. Cheryl R. Blanchard, PhD
CEO/Director/President
Ms. Sheryl L. Conley
Director
Ms. Susan L.N. Vogt
Director
Mr. Michael L. Levitz
CFO/Executive VP/Treasurer
Mr. Ian James Winward McLeod
Chief Accounting Officer/Vice President
Dr. Glenn R. Larsen, PhD
Director
Mr. David Colleran
Executive VP/General Counsel/Secretary
Mr. Stephen Richard
Director

Ownership

Institution Holdings

Trigran Investments Inc
2,139,054 (14.610%)
BlackRock Inc
1,383,877 (9.452%)
Caligan Partners LP
1,081,360 (7.386%)
Dimensional Fund Advisors LP
959,746 (6.555%)
Dimensional Fund Advisors, Inc.
821,452 (5.611%)
Vanguard Group Inc
764,045 (5.219%)
BlackRock Fund Advisors
583,877 (3.988%)
Capital Management Corporation
580,399 (3.964%)
Renaissance Technologies Corp
564,329 (3.854%)
BOOTHBAY FUND MANAGEMENT, LLC
509,522 (3.480%)

Funds Holdings

iShares Russell 2000 ETF
361,054 (2.466%)
Vanguard Institutional Extnd Mkt Idx Tr
231,016 (1.578%)
CREF Stock Account
222,171 (1.517%)
Fidelity Small Cap Index Fund
144,471 (0.987%)
DFA US Targeted Value Portfolio
137,286 (0.938%)
iShares Russell 2000 Value ETF
136,793 (0.934%)
Vanguard Russell 2000 Index Fund
49,442 (0.338%)
NT R2000 Value Index Fund - NL
43,176 (0.295%)
NT R2000 Index Fund - NL
42,870 (0.293%)
DFA US Core Equity II Fund
39,734 (0.271%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices